Medical Regulatory Affairs, Drug Approvals News

Category: Health | Total Views: 195

Latest entries from this feed

FDA approves first drug to treat tardive dyskinesia

Posted on 12 April 2017 | 2:00 pm by

The U.S. Food and Drug Administration has approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.

Related products